US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Proteomics Market Research Reports & Industry Analysis

The proteomics industry displays an exponentially growing potential, due to the quick growth of awareness in regards to personalized medicine and the resulting growth of use of proteomic technology-based advancements around the pharmaceutical sector.
RSS Feeds

Proteomics Industry Research & Market Reports

< prev 1    3  4  5  6  
Laboratory Centrifuge Market by Product (Equipment (Microcentrifuge/Ultracentrifuge), Accessories), Rotor Design, Intended Use, Application (Diagnostic/Microbiology/Proteomics/Genomics), End User (Hospital/Biotech/Pharmaceutical) - Global Forecast to 2020
4/12/2016 | published by: MarketsandMarkets
... 2020 from USD 1.53 billion in 2015, growing at a CAGR of 2.5% from 2015 to 2020. The market is categorized on the basis of product type, rotor design, intended use, application, end user, and ...  |  read more...
USD 4,650
Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020
3/23/2016 | published by: MarketsandMarkets
... therapeutic drug monitoring and increase in R&D investments will boost the growth of therapeutic drug monitoring market The therapeutic drug monitoring market is projected to reach USD 2.55 billion by 2020 from USD 1.78 billion ...  |  read more...
USD 4,650
Innovations in Proteomics Technologies (TechVision)
3/30/2016 | published by: Frost & Sullivan
... observation of the global proteomics industry, advances and technological trends across existing and emerging proteomic technologies have been detailed. While providing brief overviews for several technology clusters, the research service also covers technological snapshots, industrial ...  |  read more...
USD 4,950
2016-2020 Global Animal Health Market: Trends, Forecasts and Strategies of Key Suppliers
3/11/2016 | published by: VPGMarketResearch.com
... - Major market segments - Key geographic regions Assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as ...  |  read more...
USD 3,450
Global Protein Therapeutics Industry 2016 Market Research Report
3/1/2016 | published by: 9Dimen Research
... the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Protein Therapeutics basic information including Protein Therapeutics definition, classification, ...  |  read more...
USD 2,850
Proteins in Oncology: Drug Pathway Analyzer
2/1/2016 | published by: BioSeeker Group AB
... The rational for this plethora of treatment strategies is based on our increasing understanding of the 189 drug targets that are included in this drug-pathway analyzing tool. No less than 181 of these have been ...  |  read more...
USD 6,750
China Mouse Nerve Growth Factor Injection Industry, 2016
2/17/2016 | published by: Reports From China
... China, to build factories and take advantage of lower costs in China, to partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast the ...  |  read more...
USD 3,600
Proteomics (GLOBAL) - Industry Report
3/1/2016 | published by: Plimsoll Publishing Ltd.
... CORPORATION. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Proteomics (GLOBAL) analysis is ideal for anyone wanting to: See the market leaders Identify companies ...  |  read more...
USD 1,480
Global Peptide Therapeutics Market 2016-2020
3/4/2016 | published by: TechNavio - Infiniti Research Ltd.
... and are used to trigger, control, and maintain an individual's physiological processes. However, using peptides as therapeutic agents was always difficult as they are quite instable and cannot pass through cellular membranes. They also require ...  |  read more...
USD 2,500
Proteins in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 202 drugs. Proteins In Oncology Drug Pipeline Update lists all ...  |  read more...
USD 6,750
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025
2/8/2016 | published by: Roots Analysis
... smaller in size and can be easily synthesized, optimized and evaluated as viable therapeutic solutions for a number of diseases. These highly favourable and intrinsic characteristics of peptides have caused an evident shift in the ...  |  read more...
USD 2,199
Proteomics Research Markets: Instruments & Consumables (Mass Spectrometry, Liquid Chromatography, Electrophoresis), Disease Areas (Oncology, Cardio/Blood, Neurology, Other), Market Share and Trends
5/13/2015 | published by: Kalorama Information
... spend tens of billions of dollars on translational research, which has increased the focus on instruments capable of powerfully assaying and identifying proteins implicated in disease pathways.   This report defines the proteomics research market ...  |  read more...
USD 4,200
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, ...  |  read more...
USD 1,250
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including ...  |  read more...
USD 1,250
G-Protein Coupled Receptor (GPCR) Agonists -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, ...  |  read more...
USD 1,250
Global and Chinese Betamethasone 21-acetate (CAS 987-24-6) Industry, 2016 Market Research Report
1/20/2016 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Betamethasone 21-acetate manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides ...  |  read more...
USD 2,900
Global Proteomics Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021
11/13/2015 | published by: Occams Business Research & Consultancy
... a CAGR of 20% for the forecasted period of 2015-2021.Drug discovery and diagnostics are the key application areas for proteomics market. The rise of genetic disorders, age related disorders, birth disorders and emergence of new ...  |  read more...
USD 4,000
Global Metabolomics Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021
11/25/2015 | published by: Occams Business Research & Consultancy
... to increasing application of the technology to numerous fields such as nutrigenomics, toxicology, and Functional genomics. North America is having the largest share of market; Europe and Asia pacific follow It respectively. Some of the ...  |  read more...
USD 4,000
Global Protein Therapeutics Market 2016-2020
11/25/2015 | published by: TechNavio - Infiniti Research Ltd.
... Increased demand for and use of monoclonal antibodies is expected to drive the growth of the protein therapeutics market as it accounts for more than half of the protein therapeutics market. The monoclonal antibodies can ...  |  read more...
USD 3,000
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including ...  |  read more...
USD 1,250
< prev 1    3  4  5  6